EDGEWELL PERSONAL CARE Co: Form 10-Q for the period ended Jun 30, 2020
Filed with the SEC on Aug 4, 2020 and accepted by EDGAR at Aug 4, 2020, 16:14 ET.
Management's discussion and analysis
As filed, 55,282 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
(in millions, except per share data, unaudited)
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited Condensed Consolidated Financial Statements and the accompanying notes included in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K filed with the SEC on November 26, 2019 (the “2019 Annual Report”). The following discussion may contain forward-looking statements that reflect our plans, estimates, and beliefs and involve risks, uncertainties, and assumptions. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to these differences include those discussed within “Forward-Looking Statements” below and in Item 1A. Risk Factors and “Forward-Looking Statements” included within our 2019 Annual Report.
Forward-Looking Statements
This document contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of Edgewell Personal Care Company (“Edgewell”, “we” or “our Company”) or any of our businesses. Forward-looking statements generally can be identified by the use of words or phrases such as “believe,” “expect,” “expectation,” “anticipate,” “may,” “could,” “intend,” “belief,” “estimate,” “plan,” “target,” “predict,” “likely,” “will,” “should,” “forecast,” “outlook,” or other similar words or phrases. These statements are not based on historical facts, but instead reflect our expectations, estimates, or projections concerning future results or events, including, without limitation, the future earnings and performance of our Company or any of our businesses. Many factors outside our control (including the ongoing COVID-19 outbreak), could affect the realization of these estimates. These statements are not guarantees of performance and are inherently subject to known and unknown risks, uncertainties and assumptions that are difficult to predict and could cause our actual results to differ materially from those indicated by those statements. We cannot assure you that any of our expectations, estimates or projections will be achieved. The forward-looking statements included in this report are only made as of the date of this report, and we disclaim any obligation to publicly update any forward-looking statement to reflect subsequent events or circumstances, except as required by law. You should not place undue reliance on these statements.
In addition, other risks and uncertainties not presently known to us or that we presently consider immaterial could significantly affect the forward-looking statements. All forward-looking statements should be evaluated with the understanding of their inherent uncertainty. Risks and uncertainties include those detailed from time to time in our publicly filed documents, including in Item 1A. Risk Factors of Part I of our 2019 Annual Report, Item 1A Risk Factors of Part II of this Quarterly Report on Form 10-Q, and Item 1A Risk Factors of Part II of our Quarterly Report on Form 10-Q filed with the SEC on May 7, 2020.
Non-GAAP Financial Measures
While we report financial results in accordance with GAAP, this discussion also includes non-GAAP measures. These non-GAAP measures are referred to as “adjusted” or “organic” and exclude items such as cost of early debt retirement, incremental pandemic charges, impairment charges, restructuring charges, acquisition and integration planning costs, the disposition of the Infant and Pet Care business, business development evaluation costs, Sun Care reformulation costs, legal settlement expenses, and the amortization of intangibles. Reconciliations of non-GAAP measures are included within this Management’s Discussion and Analysis of Financial Condition and Results of Operations.
This non-GAAP information is provided as a supplement to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP. We use this non-GAAP information internally to make operating decisions and believe it is helpful to investors because it allows more meaningful period-to-period comparisons of ongoing operating results. Given the various significant events, including the Project Fuel restructuring, the efforts to acquire Harry’s, Inc. and the subsequent termination of the merger agreement with Harry's, we view the use of non-GAAP measures that take into account the impact of these unique events as particularly valuable in understanding our underlying operational results and providing insights into future performance. The information can also be used to perform trend analysis and to better identify operating trends that may otherwise be masked or distorted by the types of items that are excluded. This non-GAAP information is also a component in determining management’s incentive compensation. Finally, we believe this information provides more transparency. The following provides additional detail on our non-GAAP measures:
- We analyze our net sales and segment profit on an organic basis to better measure the comparability of results between periods. Organic net sales and organic segment profit exclude the impact of changes in foreign currency, acquisitions, and divestitures (including the disposition of the Infant and Pet Care business). This information is provided because these types of fluctuations can distort the underlying change in net sales and segment profit either positively or negatively.
- Adjusted net earnings and adjusted earnings per share are defined as net earnings and diluted earnings per share excluding items such as cost of early debt retirement, incremental pandemic charges, impairment charges, restructuring charges, acquisition and integration planning costs, the gain or loss on the disposal of a business, business development evaluation costs, Sun Care reformulation costs, legal settlement expenses, and the related tax effects of these items.
- Adjusted effective tax rate is defined as the effective tax rate excluding items such as cost of early debt retirement, incremental pandemic charges, impairment charges, restructuring charges, acquisition and integration planning costs, the gain or loss on the disposal of a business, business development evaluation costs, Sun Care reformulation costs, legal settlement expenses, and the related tax effects of these items from the income tax provision and earnings before income taxes.
- Free cash flow is defined as net cash from operating activities less net capital expenditures. Free cash flow conversion is defined as free cash flow as a percentage of net earnings adjusted for the net impact of non-cash impairments.
All comparisons are with the same period in the prior year, unless otherwise noted.
Industry and Market Data
Unless we indicate otherwise, we base the information concerning our industry contained or incorporated by reference herein on our general knowledge of and expectations concerning the industry. Our market position, market share, and industry market size are based on our estimates using internal data and external data from various industry analyses, our internal research and adjustments, and assumptions that we believe to be reasonable. We have not independently verified data from industry analyses and cannot guarantee its accuracy or completeness. In addition, we believe that data regarding the industry, market size and our market position and market share within such industry provide general guidance but are inherently imprecise and have not been verified by any independent source. Further, our estimates and assumptions involve risks and uncertainties and are subject to change based on various factors, including those discussed in “Item 1A. Risk Factors” in Part II of this Quarterly Report on Form 10-Q, the Quarterly Report on Form 10-Q filed with the SEC on May 7, 2020, and in Item 1A. Risk Factors in Part I of our 2019 Annual Report. These, and other factors, could cause results to differ materially from those expressed in the estimates and assumptions. You are cautioned not to place undue reliance on this data.
Retail sales for purposes of market size, market position and market share information are based on retail sales in U.S. dollars.
Trademarks and Trade Names
We own or have rights to use trademarks and trade names that we use in conjunction with the operation of our business, which appear throughout this Quarterly Report on Form 10-Q. We also may refer to brand names, trademarks, service marks and trade names of other companies and organizations, and these brand names, trademarks, service marks and trade names are the property of their respective owners.
Impact of COVID-19
On March 11, 2020, the World Health Organization declared COVID-19 a worldwide pandemic, which has impacted individuals, families, companies and economies around the world. Due to the uncertainty surrounding COVID-19 and its fast spreading nature, global leaders have taken significant measures to keep their people safe, which included asking people to stay home unless they are considered essential employees, closing offices and retail locations, and cancelling all non-essential travel. Governmental policies have continued to evolve, which have included phased policies with the intention to slowly reopen the local and global economies. We continue to take significant measures to protect our employees and business during the reopening process. As a result of these measures, we have incurred increased costs as a result of COVID-19 including increased employee costs, such as emergency pay and expanded benefits, and other operating costs, such as cleaning costs, personal protective equipment purchases and increased airfreight expenses, which have negatively impacted our profitability. These incremental charges totaled $3.9 in the third quarter of fiscal 2020.
The Company’s top priority during this time continues to be ensuring the health and welfare of our employees. Additional measures have been put in place at all of our manufacturing locations to ensure the safety of our employees, including thermal scanning, requiring the use of proper protective gear, making hand sanitizer widely available throughout the facilities and following social distancing guidelines. Additionally, we have implemented work-from-home policies for our employees that can work from home and have cancelled all company travel. We have not had any material operational disruption across our manufacturing and distribution facilities. There has been a slight increase in the level of absenteeism as our employees are taking intermittent leave, however, this has not caused a significant disruption in our operations.
As noted below in the discussion of our consolidated results, our earnings were negatively impacted by the COVID-19 pandemic for the three months ended June 30, 2020, which was largely driven by a decrease in demand for our Sun Care products, as the impact of the stay at home orders and phased approach to re-opening the local economies has reduced vacation travel and certain outdoor activities. This decline was partially offset by an increase in demand for our Wet Ones, due largely to consumers increased focus on personal hygiene. We expect to see continued strong demand for Wet Ones going forward. The impact that COVID-19 continues to have on our customers, their cash flows and ability to operate remains uncertain at this time. However, in some cases we have seen changes in payment patterns, requests for extended payment terms or impact to customer operations, resulting in an increase in our bad debt expense. As the duration and severity of the COVID-19 pandemic continues to affect economic conditions and therefore consumer spending and demand, we will continue to closely monitor the impact that this has on our business and customers.
We continue to closely monitor our supply chain and to date have not experienced any significant issues securing key ingredients for our products. The continued duration and severity of COVID-19 may result in disruptions related to our key suppliers going forward, however, the impact, timing and severity of potential disruptions cannot be reasonably estimated at this time.
We experienced increased volatility in foreign currency exchange rates and commodity prices in the three months ended June 30, 2020, which we believe is largely due to the economic uncertainty from COVID-19 and the depreciation of certain foreign currencies against the U.S. dollar. We expect to see continued volatility in the foreign currency exchange rates; however, we cannot estimate the impact that this will have at this time.
We expect to maintain adequate liquidity during these uncertain times. As noted in “Liquidity and Capital Resources” below, COVID-19 has not had a significant impact on our liquidity, cash flows or capital resources, including our ability to enter into the 2028 Notes or Revolving Credit Agreement. We will continue to monitor the impact that COVID-19 has on our liquidity needs and the current economic market conditions.
Significant Events
Divestiture
On December 17, 2019, we completed the sale of our Infant and Pet Care business included in the All Other segment for $122.5 which included consideration for providing services for up to one year under a transition services agreement. For further information on the divestiture of the Infant and Pet Care business, refer to Note 2 of Notes to Condensed Consolidated Financial Statements.
Project Fuel
As previously outlined, Project Fuel is an enterprise-wide transformational initiative that was launched in the second fiscal quarter of 2018 to address all aspects of our business and cost structure, simplifying and transforming our organization, structure and key processes. Project Fuel is facilitating further re-investment in our growth strategy while enabling us to achieve our desired future state operations.
We expect Project Fuel will generate $225 to $240 in total annual gross savings by the end of the 2021 fiscal year. It is expected that the savings generated will be used to fuel investments and brand building in strategic growth initiatives, offset anticipated operational cost headwinds from inflation and other rising input costs and improve our overall profitability and cash flows. Project Fuel related savings were approximately $23 and $56 for the three and nine months ended June 30, 2020, respectively, bringing cumulative savings to $194 for Project Fuel.
To implement the restructuring element of Project Fuel, we expect to incur one-time pre-tax charges of approximately $130 to $140 through the end of the 2021 fiscal year. Restructuring and related charges were $10.4 and $30.8 for the three and nine months ended June 30, 2020, respectively, bringing cumulative charges to $126 for the project.
Capital expenditures for Project Fuel were $6.1 and $15.4 for the three and nine months ended June 30, 2020, respectively.
For further information on our restructuring projects, refer to Note 3 of Notes to Condensed Consolidated Financial Statements.
Executive Summary
The following is a summary of key results for the third quarter and first nine months of fiscal 2020 compared to the third quarter and first nine months of fiscal 2019. Net earnings and earnings per share (“EPS”) for the periods presented were impacted by cost of early debt retirement, incremental pandemic charges, restructuring charges, acquisition and integration planning costs, the gain on the disposition of the Infant and Pet Care business, Feminine and Infant Care evaluation costs, legal settlement expenses, and the impact of the Tax Cuts and Jobs Act (“Tax Act”), as described in the table below. The impact of these items on reported net earnings and EPS are provided as a reconciliation of net earnings and EPS to adjusted net earnings and adjusted diluted EPS, both of which are non-GAAP measures.
Third Quarter of Fiscal 2020
- Net sales in the third quarter of fiscal 2020 were $483.9, down 20.6% compared to the prior year quarter, inclusive of a 5.1% decline from the sale of the Infant and Pet Care business and a 0.8% decline due to currency movements. Excluding the divestiture of the Infant and Pet Care business and currency movements, organic net sales decreased 14.7% compared to the prior year quarter, due to declines in Sun and Skin Care and Wet Shave, both of which have been impacted by decreased volumes that we believe were driven in part by COVID-19, and was partially offset by an increase in Wet Ones.
- Net earnings in the third quarter of fiscal 2020 were $4.7 compared to a loss of $460.7 in the prior year quarter. On an adjusted basis, as illustrated in the following table, net earnings for the third quarter of fiscal 2020 decreased 40.7% to $35.9. The decline was primarily driven by lower sales from the COVID-19 pandemic. Additionally, the sale of the Infant and Pet Care business further reduced earnings compared to the prior year quarter. The decline in earnings associated with lower net sales was partially offset by reduced advertising and promotion (“A&P”) spend during the quarter across all segments.
- Net earnings per diluted share during the third quarter of fiscal 2020 were $0.09 compared to a loss of $8.51 in the prior year quarter. On an adjusted basis, as illustrated in the following table, net earnings per diluted share during the third quarter of fiscal 2020 was $0.66 compared to $1.11 in the prior year quarter.
| Quarter Ended June 30, Net Earnings 2020 | 2019 | Diluted EPS 2020 | 2019 | |
|---|---|---|---|---|
| Net Earnings (Loss) and Diluted EPS — GAAP | $4.7 | $(460.7) | $0.09 | $(8.51) |
| Impairment charges | — | 570.0 | — | 10.53 |
| Restructuring and related costs, net | 10.4 | 8.9 | 0.19 | 0.17 |
| Acquisition and integration planning | 0.3 | 1.9 | 0.01 | 0.03 |
| Cost of early retirement of long-term debt | 26.2 | — | 0.48 | — |
| COVID-19 expenses | 3.9 | — | 0.07 | — |
| Feminine and Infant Care evaluation costs | — | 0.5 | — | 0.01 |
| Sun Care reformulation costs | — | 1.0 | — | 0.02 |
| Impact of dilutive shares | — | — | — | (0.01) |
| Income taxes (1) | (9.6) | (61.1) | (0.18) | (1.13) |
| Adjusted Net Earnings and Adjusted Diluted EPS — Non-GAAP | $35.9 | $60.5 | $0.66 | $1.11 |
| Weighted-average shares outstanding — Diluted | 54.6 | 54.1 |
(1) Includes Income tax expense for adjustments to Net Earnings and Diluted EPS — GAAP for fiscal 2020 and 2019.
First Nine Months of Fiscal 2020
- Net sales for the first nine months of fiscal 2020 decreased 9.4% to $1,460.9, inclusive of a 4.0% decline from the sale of the Infant and Pet Care business and a 0.7% decline due to currency movements. Excluding the divestiture of the Infant and Pet Care business and currency movements, organic net sales decreased 4.7% compared to the prior year period, due to declines in Sun and Skin Care and Wet Shave from decreased volumes that were driven in part by COVID-19, which was partially offset by an increase in volumes in Wet Ones.
- Net earnings for the first nine months of fiscal 2020 were $46.6 compared to a loss of $412.9 in the prior year. On an adjusted basis, as illustrated in the following table, net earnings for the first nine months of fiscal 2020 decreased 18.3% to $116.2. The decline was primarily driven by lower sales from the COVID-19 pandemic, especially in the third quarter of fiscal 2020. Additionally, the sale of the Infant and Pet Care business further reduced earnings compared to the prior year quarter. The decline in earnings was partially offset by reduced A&P spend across all segments.
- Net earnings per diluted share during the first nine months of fiscal 2020 were $0.86 compared to a loss of $7.63 in the prior year period. On an adjusted basis, as illustrated in the following table, net earnings per diluted share during the first nine months of fiscal 2020 were $2.13 compared to $2.62 in the prior year quarter.
| Nine Months Ended June 30, Net Earnings 2020 | 2019 | Diluted EPS 2020 | 2019 | |
|---|---|---|---|---|
| Net Earnings (Loss) and Diluted EPS — GAAP | $46.6 | $(412.9) | $0.86 | $(7.63) |
| Impairment charges | — | 570.0 | — | 10.53 |
| Restructuring and related costs, net | 30.8 | 42.8 | 0.57 | 0.79 |
| Acquisition and integration planning | 32.0 | 2.9 | 0.58 | 0.05 |
| Cost of early retirement of long-term debt | 26.2 | — | 0.48 | — |
| Gain on sale of Infant and Pet Care assets | (4.1) | — | (0.08) | — |
| COVID-19 expenses | 3.9 | — | 0.07 | — |
| Feminine and Infant Care evaluation costs | 0.3 | 1.5 | 0.01 | 0.03 |
| Sun Care reformulation costs | — | 1.5 | — | 0.03 |
| Legal settlement expense | — | 0.9 | — | 0.02 |
| Impact of dilutive shares | — | — | — | (0.01) |
| Income taxes (1) | (19.5) | (64.5) | (0.36) | (1.19) |
| Adjusted Net Earnings and Adjusted Diluted EPS — Non-GAAP | $116.2 | $142.2 | $2.13 | $2.62 |
| Weighted-average shares outstanding — Diluted | 54.5 | 54.1 |
(1) Includes Income tax expense for adjustments to Net Earnings and Diluted EPS — GAAP for fiscal 2020 and 2019. Additionally, the nine months ended June 30, 2019 was impacted $4.7 as a result of the transition tax from the Tax Act.
Operating Results
The following table presents changes in net sales for the third quarter and first nine months of fiscal 2020, as compared to the corresponding period in fiscal 2019, and provides a reconciliation of organic net sales to reported amounts.
Net Sales
| Net Sales - Total Company Period Ended June 30, 2020 | Q3 | % Chg | Nine Months | % Chg |
|---|---|---|---|---|
| Net sales - prior year | $609.2 | $1,613.0 | ||
| Organic | (89.4) | (14.7)% | (76.4) | (4.7)% |
| Impact of Infant and Pet Care divestiture | (31.3) | (5.1)% | (64.0) | (4.0)% |
| Impact of currency | (4.6) | (0.8)% | (11.7) | (0.7)% |
| Net sales - current year | $483.9 | (20.6)% | $1,460.9 | (9.4)% |
29
For the third quarter of fiscal 2020, net sales were $483.9, a 20.6% decrease when compared with the prior year period. Excluding the impact of the Infant and Pet Care business divestiture and currency movements, organic net sales decreased 14.7% versus the prior year period. The decline in organic net sales in the quarter was largely due to the ongoing COVID-19 pandemic and the related stay at home orders and travel restrictions which resulted in lower consumer demand and decreases in net sales for our Wet Shave and Sun Care products. Those decreases were partially offset by increased sales of our Wet Ones products driven by on-going demand strength, in part related to COVID-19. We estimated that when excluding the COVID-19 related impacts, organic net sales were flat to slightly down with the prior year period and consistent with recent trends. The estimated impact of the COVID-19 pandemic on net sales at the product and category level was determined through a detailed analysis of many factors, including rolling weekly and monthly net sales trends prior to COVID-19, historical and current order patterns by customer compared to the prior year period and segment performance in the context of overall category trends. This is our best estimate and there can be no assurances that our estimate reflects the actual COVID-19 impact to net sales.
For the first nine months of fiscal 2020, net sales decreased 9.4%. Excluding the impact of the Infant and Pet Care business divestiture and currency movements, organic net sales decreased 4.7% versus the prior year period. The decrease in sales is primarily driven by declines in the sales for our Sun Care and Wet Shave products as a result of COVID-19. This was partially offset by increased demand for Wet Ones in part due to COVID-19.
For further discussion regarding net sales, including a summary of reported versus organic changes, see “Segment Results.”
Gross Profit
Gross profit was $222.7 during the third quarter of fiscal 2020, as compared to $292.2 in the prior year period. Gross margin as a percent of net sales for the third quarter of fiscal 2020 was 46.0%, representing a 200-basis point decline over the prior year gross margin percentage of 48.0%. Excluding the impact of the incremental one-time costs associated with the COVID-19 pandemic, restructuring charges, and Sun Care reformulation charges, gross margin percentage declined 130 basis points compared to the prior year period. The decline was a result of unfavorable category mix, and was partially offset by a price increase in Sun Care and favorable commodity costs.
Gross profit was $658.8 during the first nine months of fiscal 2020, as compared to $736.6 in the prior year period. Gross margin as a percent of net sales for the first nine months of fiscal 2020 was 45.1%, down 60 basis points as compared to the prior year period. The decline was driven by unfavorable category mix and increased trade spend. The decline in gross margin was partially offset by the divestiture of the Infant and Pet Care business which had a lower gross margin.
Selling, General and Administrative Expense
Selling, general and administrative expense (“SG&A”) was $91.3 in the third quarter of fiscal 2020, or 18.9% of net sales, as compared to $94.8 in the prior year period, or 15.6% of net sales. Excluding SG&A associated with acquisitions and integration planning, Project Fuel, and business development evaluation expenses, SG&A was $1.9 below the prior year period, driven mostly by lower travel and other discretionary spend.
SG&A was $307.8 in the first nine months of fiscal 2020, or 21.1% of net sales, as compared to $280.2 in the prior year period, or 17.4% of net sales. Excluding SG&A costs associated with acquisition and integration planning, Project Fuel, the divestiture of the Infant and Pet Care business, and the impact of foreign currency fluctuations, SG&A was down $4.3 compared to the nine months ended June 30, 2019 as increased personnel and consulting costs and corporate donations were offset by reduced indirect spend.
Advertising and Sales Promotion Expense
For the third quarter of fiscal 2020, A&P was $67.5, down $24.3 compared to the prior year period. A&P spending as a percent of net sales was 13.9%, compared to 15.1% in the prior year period. The decline in A&P expense was primarily caused by the COVID-19 pandemic as the Company lowered A&P spend due to the reduction in demand across multiple product lines. Additionally, the divestiture of the Infant and Pet Care business decreased A&P expense which totaled $2.3 in the prior year quarter. The decline in expense was spread across all segments, with the largest decline in Wet Shave.
For the first nine months of fiscal 2020, A&P was $155.6, down $35.7 as compared to the prior year period. A&P as a percent of net sales was 10.7%, as compared to 11.9% in the prior year period. The decline in A&P expense was primarily caused by the COVID-19 pandemic as the Company lowered A&P spend in the third quarter due to the reduction in demand across multiple product lines. Additionally, A&P declined by $4.5 due to the sale of the Infant and Pet Care business.
Research and Development Expense
Research and development expense (“R&D”) for the third quarter of fiscal 2020 was $12.4, compared to $12.9 in the prior year period. As a percent of net sales, R&D was 2.6% in the third quarter of fiscal 2020 compared to 2.1% in the prior year period.
R&D for the first nine months of fiscal 2020 was $40.1, compared to $39.5 in the prior year period. As a percent of net sales, R&D increased 30 basis points to 2.7% in the first nine months of fiscal 2020 from 2.4% in the prior year. R&D expense was flat compared to the prior year as driven by incremental investments in resources and capabilities in support of the Company’s focus on innovation and development primarily in the Sun and Skin Care segment offset by slightly reduced investment in Wet Shave.
Interest Expense Associated with Debt
Interest expense associated with debt for the third quarter of fiscal 2020 was $15.5 compared to $15.6 in the prior year quarter. For the first nine months of fiscal 2020, interest expense was $43.7 compared to $48.0 in the prior year period. The decline in interest expense was the result of lower average outstanding debt primarily as a result of the repayment of the $185 term loan due April 2019 in the second quarter of fiscal 2019. Additionally, there were no borrowings under the Revolving Credit Facility as of June 30, 2020. Finally, we incurred $26.2 of costs for the early retirement of the $600 2021 Senior Notes in the third quarter and nine months ended June 30, 2020.
Other (Income) Expense, Net
Other (income) expense, net was $3.5 of income in the third quarter of fiscal 2020 compared to expense of $2.7 in the prior year period. Other (income) expense, net was an expense of $5.8 during the first nine months of fiscal 2020 compared to expense of $1.3 during first nine months of fiscal 2019. The increase in income the third quarter was largely related to the recovery of local currencies in the aftermath of significant declines in the second quarter caused by the COVID-19 pandemic resulting in favorable revaluation of balance sheet exposures and higher settlements positive settlements of foreign currency hedges.
Income Tax Provision
The effective tax rate for the first nine months of fiscal 2020 was 26.1% compared to 4.3% in the prior year period. The effective tax rate for the prior period year reflects a small tax benefit on a net loss, primarily due to the impairment of goodwill and intangible assets, a portion of which are non-deductible. The rate was also unfavorably impacted by a $4.7 net transitional charge resulting from the enactment of the Tax Act in the first quarter of fiscal 2019. Excluding the tax impact of impairment charges, restructuring charges, acquisition and integration planning costs, cost of early debt retirement, the gain on the disposition of the Infant and Pet Care business, incremental COVID-19 pandemic expenses, Feminine and Infant Care evaluation costs, and legal settlement expenses, the adjusted effective tax rate was 23.7% and 24.4% for the first nine months of fiscal 2020 and fiscal 2019, respectively. Both the effective tax rate and the adjusted effective tax rate are dependent upon the mix of earnings in various tax jurisdictions.
The following table presents a reconciliation of the adjusted effective tax rate, which is a non-GAAP measure:
| Nine Months Ended June 30, 2020 Reported | Adjustments (1) | Adjusted (Non-GAAP) | Nine Months Ended June 30, 2019 Reported | Adjustments (1) | Adjusted (Non-GAAP) | |
|---|---|---|---|---|---|---|
| Earnings before income taxes | $63.1 | $89.1 | $152.2 | $(431.4) | $619.6 | $188.2 |
| Income tax provision | 16.5 | 19.5 | 36.0 | (18.5) | 64.5 | 46.0 |
| Net earnings | $46.6 | $69.6 | $116.2 | $(412.9) | $555.1 | $142.2 |
| Effective tax rate | 26.1% | 4.3% | ||||
| Adjusted effective tax rate | 23.7% | 24.4% |
(1) Includes adjustments for the impact of the Tax Act, cost of early debt retirement, incremental COVID-19 pandemic charges, impairment charges, restructuring charges, acquisition and integration planning costs, the gain or loss on the disposal of a business, business development evaluation costs, Sun Care reformulation costs and legal settlement expense. See reconciliation of net earnings to adjusted net earnings.
Segment Results
The following tables present changes in segment net sales and segment profit for the third quarter and first nine months of fiscal 2020, compared to the corresponding period in fiscal 2019, and provide a reconciliation of organic segment net sales and organic segment profit to reported amounts. For a reconciliation of segment profit to Earnings before income taxes, refer to Note 14 of Notes to Condensed Consolidated Financial Statements.
Our operating model includes some shared business functions across the segments, including product warehousing and distribution, transaction processing functions and, in most cases, a combined sales force and management teams. We apply a fully allocated cost basis, in which shared business functions are allocated between the segments. As a result of the divestiture of the Infant and Pet Care business, some shared costs which were previously allocated to the All Other segment are now being allocated to the Wet Shave, Sun and Skin Care and Feminine Care segments, with the largest impact to Wet Shave, as noted in the discussion below.
Wet Shave
| Net Sales - Wet Shave Period Ended June 30, 2020 | Q3 | % Chg | Nine Months | % Chg |
|---|---|---|---|---|
| Net sales - prior year | $327.7 | $909.8 | ||
| Organic | (46.3) | (14.1)% | (65.9) | (7.2)% |
| Impact of currency | (3.4) | (1.1)% | (8.4) | (1.0)% |
| Net sales - current year | $278.0 | (15.2)% | $835.5 | (8.2)% |
Wet Shave net sales for the third quarter of fiscal 2020 decreased 15.2%, inclusive of a 1.1% decline due to currency movements. Excluding the impact of currency movements, organic net sales decreased $46.3, or 14.1%, primarily driven by volume declines related to the COVID-19 pandemic which impacted all products and regions as consumption fell globally. In addition to the impact of the COVID-19 pandemic, net sales fell in North America from unfavorable product mix and certain distribution losses.
Wet Shave net sales for the first nine months of fiscal 2020 decreased 8.2%, inclusive of a 1.0% decline due to currency movements. Excluding the impact of currency movements, organic net sales decreased $65.9, or 7.2%. The decline in organic net sales was driven by reduction in category sales and demand from the COVID-19 pandemic, impacting all regions. Volumes declined in Men’s Systems and Disposables partially offset by slight gains in Women’s Systems. Price mix unfavorably impacted all products specifically in North America related to product mix. North America organic net sales were down 7.8%, while International organic net sales decreased 6.8%.
| Segment Profit - Wet Shave Period Ended June 30, 2020 | Q3 | % Chg | Nine Months | % Chg |
|---|---|---|---|---|
| Segment profit - prior year | $54.1 | $164.8 | ||
| Organic | (8.1) | (15.0)% | (20.3) | (12.3)% |
| Impact of currency | (1.4) | (2.6)% | (2.5) | (1.5)% |
| Segment profit - current year | $44.6 | (17.6)% | $142.0 | (13.8)% |
Wet Shave segment profit for the third quarter of fiscal 2020 was $44.6, down $9.5, or 17.6%, from the prior year period, inclusive of the impact of currency movements. Excluding the impact of currency movements, organic segment profit decreased $8.1, or 15.0%, driven by lower volumes from the COVID-19 pandemic and unfavorable price mix, partially offset by lower A&P spend.
Wet Shave segment profit for the first nine months of fiscal 2020 was $142.0, down $22.8 or 13.8%, from the prior year period, inclusive of the impact of currency movements. Excluding the impact of currency movements, organic segment profit decreased $20.3, or 12.3%, primarily due to lower sales volumes across all categories, primarily attributable to COVID-19 and unfavorable price mix as a result of increased trade spend in North America. The gross margin declines were partially offset by lower A&P support across all brands.
Sun and Skin Care
Sun and Skin Care segment net sales and profit are affected by the seasonality of sun care products. As a result, segment net sales and profit historically have been higher in the second and third quarters of the fiscal year. Net Sales and Operating Profit for manicure kits were reclassified to Sun and Skin Care for both the current and prior year periods as these products were not a part of the divestiture of the Infant and Pet Care business. The impact of recasting the prior period segment information was not material.
| Net Sales - Sun and Skin Care Period Ended June 30, 2020 | Q3 | % Chg | Nine Months | % Chg |
|---|---|---|---|---|
| Net sales - prior year | $169.3 | $382.7 | ||
| Organic | (31.3) | (18.5)% | (10.2) | (2.7)% |
| Impact of currency | (1.1) | (0.6)% | (3.0) | (0.7)% |
| Net sales - current year | $136.9 | (19.1)% | $369.5 | (3.4)% |
Sun and Skin Care net sales for the third quarter of fiscal 2020 decreased 19.1%, from the prior year period, inclusive of a 0.6% decline due to currency movements. Excluding the impact of currency movements, organic net sales decreased $31.3, or 18.5%, primarily driven by reduced category demand of Sun Care products globally from the COVID-19 pandemic. The declines in Sun Care were partially offset by growth in Wet Ones of 52% and Grooming of 5%. The growth in Wet Ones included a positive impact of the COVID-19 pandemic while Grooming net sales grew despite category declines as a result of the COVID-19 pandemic.
Sun and Skin Care net sales for the first nine months of fiscal 2020 decreased 3.4%, inclusive of a 0.7% decline due to currency movements. Excluding the impact of currency movements, organic net sales decreased $10.2, or 2.7%, related to declines in volumes of Sun Care products due to the COVID-19 pandemic primarily in North America and Latin America. The declines in Sun Care were partially offset by growth in Wet Ones and Grooming products, primarily Bulldog. Price mix was favorable across the segment related to a price increase in Sun Care in North America.
| Segment Profit - Sun and Skin Care Period Ended June 30, 2020 | Q3 | % Chg | Nine Months | % Chg |
|---|---|---|---|---|
| Segment profit - prior year | $42.4 | $82.7 | ||
| Organic | (18.8) | (44.3)% | (13.9) | (16.8)% |
| Impact of currency | (0.1) | (0.3)% | (0.9) | (1.1)% |
| Segment profit - current year | $23.5 | (44.6)% | $67.9 | (17.9)% |
Segment profit for the third quarter of fiscal 2020 was $23.5, a decrease of $18.9, or 44.6%, from the prior year quarter, inclusive of the impact of currency movements. Excluding the impact of currency movements, organic segment profit decreased $18.8, or 44.3%, driven by lower volumes in Sun Care, higher warehousing costs and increased reserves for obsolete inventory. These declines were partially offset by year over year price increases in the Sun Care business, lower A&P spend and favorable materials pricing.
Segment profit for the first nine months of fiscal 2020 was $67.9, a decrease of $14.8, or 17.9%, inclusive of currency movements. Excluding the impact of currency movements, organic segment profit decreased $13.9, or 16.8%, driven primarily by lower sales volumes in Sun Care partially offset by higher sales in Wet Ones and Grooming products. Additionally, Sun and Skin Care was impacted by unfavorable cost mix driven by lower Sun Care production. These declines were partially offset by lower A&P spend to combat the lower demand for the Sun Care category.
Feminine Care
| Net Sales - Feminine Care Period Ended June 30, 2020 | Q3 | % Chg | Nine Months | % Chg |
|---|---|---|---|---|
| Net sales - prior year | $80.9 | $230.2 | ||
| Organic | (11.8) | (14.6)% | (0.8) | (0.4)% |
| Impact of currency | (0.1) | (0.1)% | (0.3) | (0.1)% |
| Net sales - current year | $69.0 | (14.7)% | $229.1 | (0.5)% |
33
Feminine Care net sales for the third quarter of fiscal 2020 decreased $11.9, or 14.7%, from the prior year period, inclusive of a 0.1% decline due to the impact of currency movements. The decline in net sales in the quarter was driven by reduced volumes in the quarter mainly due to the negative effect of consumer pantry loading that took place at the beginning of the COVID-19 pandemic shifting the timing of sales. Additionally, Feminine Care experienced heightened competitive pressure, category declines, distribution losses and unfavorable price mix, driven by increased trade and coupon spend in North America.
Feminine Care net sales for the first nine months of fiscal 2020 decreased $1.1, or 0.5%, inclusive of a 0.1% decline due to the impact of currency movements. Net sales were roughly flat, as unfavorable price mix from trade promotions in North America were mostly offset by higher sales volumes.
| Segment Profit - Feminine Care Period Ended June 30, 2020 | Q3 | %Chg | Nine Months | %Chg |
|---|---|---|---|---|
| Segment profit - prior year | $15.5 | $36.7 | ||
| Organic | (3.4) | (21.9)% | 6.7 | 18.3% |
| Impact of currency | (0.1) | (0.6)% | — | —% |
| Segment profit - current year | $12.0 | (22.5)% | $43.4 | 18.3% |
Feminine Care segment profit for the third quarter of fiscal 2020 was $12.0, a decrease of $3.5, or 22.5% from the prior year period. The decline was driven by lower volumes from the prior quarter consumer pantry loading due to the COVID-19 pandemic and unfavorable price mix, partly offset by lower A&P spending.
Feminine Care segment profit for the first nine months of fiscal 2020 was $43.4, an increase of $6.7, or 18.3%, from the prior year period, primarily due to higher sales volumes, favorable cost mix due to lower materials and warehouse and distribution costs and lower A&P spend, partially offset by lower price mix from increased promotions.
All Other
The Infant and Pet Care business divestiture completed in December 2019 disposed of the entirety of operations of the All Other segment. Net Sales and Operating Profit for the Company’s manicure kits were reclassified to Sun and Skin Care for both the current and prior year periods. The results below represent segment performance through the date of divestiture.
| Net Sales - All Other Period Ended June 30, 2020 | Q3 | %Chg | Nine Months | %Chg |
|---|---|---|---|---|
| Net sales - prior year | $31.3 | $90.3 | ||
| Organic | — | —% | 0.5 | 0.6% |
| Impact of divestiture | (31.3) | (100.0)% | (64.0) | (70.9)% |
| Impact of currency | — | —% | — | —% |
| Net sales - current year | $— | (100.0)% | $26.8 | (70.3)% |
All Other net sales for the first nine months of fiscal 2020 decreased 70.3%. Excluding the impact of the divestiture of the Infant and Pet Care business, organic net sales increased $0.5 or 0.6%.
| Segment Profit - All Other Period Ended June 30, 2020 | Q3 | %Chg | Nine Months | %Chg |
|---|---|---|---|---|
| Segment profit - prior year | $3.4 | $10.2 | ||
| Organic | — | —% | 0.5 | 4.9% |
| Impact of divestiture | (3.4) | (100.0)% | (7.6) | (74.5)% |
| Impact of currency | — | —% | — | —% |
| Segment profit - current year | $— | (100.0)% | $3.1 | (69.6)% |
All Other segment profit for the first nine months of fiscal 2020 was $3.1, a decrease of $7.1 or 69.6%, compared to the prior year period. Excluding the impact of the divestiture of the Infant and Pet Care business, organic segment profit increased 4.9%.
General Corporate and Other Expenses
| Quarter Ended June 30, 2020 | 2019 | Nine Months Ended June 30, 2020 | 2019 | |
|---|---|---|---|---|
| Corporate expenses | $17.7 | $13.1 | $41.9 | $43.5 |
| Impairment charges | — | 570.0 | — | 570.0 |
| Restructuring and related costs | 10.4 | 8.9 | 30.8 | 42.8 |
| Acquisition and integration planning costs | 0.3 | 1.9 | 32.0 | 2.9 |
| Cost of early retirement of long-term debt | 26.2 | — | 26.2 | — |
| Gain on sale of Infant and Pet Care business | — | — | (4.1) | — |
| COVID-19 expenses | 3.9 | — | 3.9 | — |
| Feminine and Infant Care evaluation costs | — | 0.5 | 0.3 | 1.5 |
| Legal settlement expense | — | — | — | 0.9 |
| Sun Care reformulation | — | 1.0 | — | 1.5 |
| General corporate and other expenses | $58.5 | $595.4 | $131.0 | $663.1 |
| % of net sales | 12.1% | 97.7% | 9.0% | 41.1% |
For the third quarter of fiscal 2020, general corporate expenses were $17.7, or 3.7% of net sales, compared to $13.1, or 2.2% of net sales, in the prior year quarter. For the third quarter of fiscal 2020, the increase in corporate expense relates to higher personnel costs including deferred compensation and other benefit expenses partially offset by Project Fuel savings. For the first nine months of fiscal 2020, general corporate expenses were $41.9, or 2.9% of net sales, compared to $43.5, or 2.7% of net sales, in the prior year period. For the nine months ended June 30, 2020, the decrease in corporate expenses was related to Project Fuel savings and legal fees incurred in the prior year period partially offset by higher personnel and benefit costs related to the COVID-19 pandemic.
For the third quarter and first nine months of fiscal 2020, the Company incurred expenses associated with the early retirement of the $600 Senior Notes due 2021, including the recognition of remaining debt issuance costs and interest expense.
Liquidity and Capital Resources
To date, COVID-19 has not had a significant impact on our liquidity or capital resources. However, the continued spread of COVID-19 has led to disruption and volatility in the global capital markets, which, depending on future developments, could impact our capital resources and liquidity in the future.
At June 30, 2020, a portion of our cash balances were located outside the U.S. Given our extensive international operations, a significant portion of our cash is denominated in foreign currencies. We manage our worldwide cash requirements by reviewing available funds among the many subsidiaries through which we conduct business and the cost effectiveness with which those funds can be accessed. We generally repatriate a portion of current year earnings from select non-U.S. subsidiaries only if the economic cost of the repatriation is not considered material.
The counterparties to deposits consist of major financial institutions. We consistently monitor positions with, and credit ratings of, counterparties both internally and by using outside ratings agencies.
Our total borrowings were $1,268.4 at June 30, 2020 including $18.4 tied to variable interest rates. Our total borrowings at September 30, 2019 were $1,231.4.
On May 22, 2020, the Company entered into a new unsecured indenture agreement for 5.5% Senior Notes in the amount of $750 due June 1, 2028 (“2028 Notes”). The Company used a portion of the net proceeds of the 2028 Notes to satisfy and discharge the obligations outstanding for the $600 Senior Notes due 2021 (“2021 Notes”). The remainder of the net proceeds will be used to pay our fees and expenses and for general corporate purposes, which may include, but are not limited to, the repayment of outstanding indebtedness, working capital, capital expenditures and acquisitions. The Company’s $500 senior notes are due May 24, 2022. We expect to refinance these notes prior to their maturity.
On April 3, 2020, we replaced our former unsecured revolving credit facility in the U.S. with a new secured revolving credit facility in an aggregate principal amount of $425 (the “Revolving Credit Facility”). Taking into account outstanding letters of credit of $8.7, as of June 30, 2020, $416.3 was available under the Revolving Credit Facility as of June 30, 2020. At September 30, 2019, we had outstanding borrowings of $117.0 under our prior senior unsecured revolving credit agreement dated as of June 1, 2015, as amended, supplemented or modified from time to time among the Company, as borrower, JPMorgan Chase Bank, N.A., as administrative agent, and the other parties thereto, and the related Subsidiary Guaranty Agreement dated as of June 30, 2015 (the “Prior Revolving Facility” and, collectively with the Revolving Credit Facility, the “Revolving Credit Facilities”).
We had outstanding international borrowings, recorded in Notes payable, of $18.4 and $14.4 as of June 30, 2020 and September 30, 2019, respectively.
Historically, we have generated and expect to continue to generate positive cash flows from operations. Our cash flows are affected by the seasonality of our Sun Care products, typically resulting in higher net sales and increased cash generated in the second and third quarter of each fiscal year. While we cannot reasonably estimate the full impact COVID-19 will have on our cash flows, we believe our cash on hand, cash flows from operations, additional proceeds from the 2028 Notes and available borrowing under the Revolving Credit Facility will be sufficient to satisfy our future working capital requirements, interest payments, research and development activities, capital expenditures, and other financing requirements for at least the next 12 months. We will continue to monitor our cash flows, spending and liquidity needs.
Short-term financing needs primarily consist of working capital requirements, and principal and interest payments on our long-term debt. Long-term financing needs will depend largely on potential growth opportunities, including acquisition activity and repayment or refinancing of our long-term debt obligations. We may, from time-to-time, seek to repurchase shares of our common stock. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. Our long-term liquidity may be influenced by our ability to borrow additional funds, renegotiate existing debt, and raise equity under terms that are favorable to us.
The expected minimum required contribution to our pension plans in fiscal 2020 is $10.4; however, discretionary contributions may also be made. During the first nine months of fiscal 2020 we contributed $5.0 to our pension plans.
As of June 30, 2020, we were in compliance with the provisions and covenants associated with our debt agreements.
Cash Flows
A summary of our cash flow activities is provided in the following table:
| Net cash from (used by): | Nine Months Ended June 30, 2020 | 2019 |
|---|---|---|
| Operating activities | $118.6 | $98.2 |
| Investing activities | 71.3 | (26.9) |
| Financing activities | (21.6) | (57.5) |
| Effect of exchange rate changes on cash | 2.0 | (1.2) |
| Net increase in cash and cash equivalents | $170.3 | $12.6 |
Operating Activities
Cash flow from operating activities was $118.6 during the first nine months of fiscal 2020, compared to cash inflows of $98.2 during the same period in the prior year. The improvement in cash generated from operating cash flows was primarily related to improved working capital due to lower inventory levels, reflective of efforts to optimize inventory levels across all portfolios, and partially offset by lower net earnings as sales were reduced due to the COVID-19 pandemic.
Investing Activities
Cash flow from investing activities was $71.3 during the first nine months of fiscal 2020, compared to cash used by investing activities of $26.9 during the same period in the prior year. During the nine months ended June 30, 2020, we collected $95.8 of proceeds from the sale of the Infant and Pet Care business. Capital expenditures were $26.9 during the first nine months of fiscal 2020 compared to $38.7 during the same period in the prior year. Additionally, other investing cash inflows related to collection of receivables from the $150 uncommitted master accounts receivable purchase agreement with The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the purchaser (“Accounts Receivable Facility”) totaled $3.9 and $9.0 during the first nine months of fiscal 2020 and 2019, respectively, as a result of collections on the deferred purchase price of accounts receivables sold.
Financing Activities
Net cash used by financing activities was $21.6 during the first nine months of fiscal 2020, compared to net cash used by financing activities of $57.5 during the same period in the prior year. During the first nine months of fiscal 2020, we made repayments of $117.0 on the Prior Revolving Facility. The Company replaced its $600 Senior Notes due 2021 with the issuance of $750 Senior Notes due 2028. Additional financing cash outflows incurred related costs of early debt retirement of the 2021 Senior Notes totaling $26.2 and debt issuance costs totaling $10.4. Additionally, financing outflows associated with the Accounts Receivable Facility were $14.4 during the first nine months of fiscal 2020 compared to financing inflows of $5.6 in the prior year period.
Commitments and Contingencies
Contractual Obligations
During the first nine months of fiscal 2020, net repayments on the Revolving Credit Facilities were $117.0. As of June 30, 2020, future minimum repayments of debt were: $500.0 in fiscal 2022 and $750.0 in fiscal 2028.
There have been no other material changes in our contractual obligations since the presentation in our 2019 Annual Report.
Supplemental Guarantor Financial Information
The Company issued Senior Notes in May 2012 and May 2020 (collectively, the “Notes”) and entered into the Revolving Credit Facility on April 3, 2020, all of which are fully and unconditionally guaranteed on a joint and several basis by the Company’s existing and future material direct and indirect domestic subsidiaries that are guarantors of any of the Company’s credit agreements or other indebtedness for borrowed money (the “Guarantors”). The Guarantors are 100% owned either directly or indirectly by the Company and jointly and severally guarantee the Company’s obligations under the Notes and the Revolving Credit Agreement. The Company’s subsidiaries organized outside of the U.S. and certain domestic subsidiaries which are not guarantors of any of the Company’s other indebtedness (collectively, the “Non-Guarantors”), do not guarantee the Notes. The subsidiary guarantee with respect to the Notes is subject to release upon sale of all of the capital stock of the subsidiary guarantor; if the guarantee under the Company’s credit agreements and other indebtedness for borrowed money is released or discharged (other than due to payment under such guarantee); or when the requirements for legal defeasance are satisfied or the obligations are discharged in accordance with the indenture. Further detail on the 2028 Notes and Revolving Credit Facility is included in Note 10 of Notes to Consolidated Financial Statements
The following tables present summarized financial information for the Parent and the Guarantors on a combined basis after elimination of (i) intercompany transactions and balances among the Parent and the Guarantors and (ii) equity in earnings from and investments in any subsidiary that is a non-Guarantor.
| Summarized Statement of Operations | Nine Months Ended June 30, 2020 |
|---|---|
| Net sales | $1,011.0 |
| Gross profit | 403.5 |
| Net loss | (3.8) |
| Summarized Balance Sheet Assets | June 30, 2020 | September 30, 2019 |
|---|---|---|
| Current assets | $546.5 | $299.1 |
| Non-current assets | 1,737.8 | 1,745.5 |
| Liabilities and Shareholder’s Equity | ||
| Current liabilities | 315.2 | 487.5 |
| Non-current liabilities | 1,527.1 | 1,393.2 |
38
Market risk
As filed, 1,194 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The market risk inherent in our financial instruments and positions represents the potential loss arising from adverse changes in currency rates, commodity prices, and interest rates. At times, we enter into contractual arrangements (derivatives) to reduce these exposures. For further information on our foreign currency derivative instruments, refer to Note 13 of Notes to Condensed Consolidated Financial Statements. As of June 30, 2020, there were no open derivative or hedging instruments for future purchases of raw materials or commodities. Our exposure to interest rate risk relates primarily to our variable-rate debt instruments, which currently bear interest based on LIBOR plus margin. As of June 30, 2020, our outstanding variable-rate debt included $18.4 related to our international, variable-rate note payable. Assuming a one-percent increase in the applicable interest rates, annual interest expense on these variable-rate debt instruments would not increase materially.
There have been no material changes in our assessment of market risk sensitivity since our presentation of Quantitative and Qualitative Disclosures About Market Risk in our 2019 Annual Report on Form 10-K.
Controls and procedures
As filed, 1,196 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized, and reported within the specified time periods, and that such information is accumulated and communicated to management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), as appropriate, to allow timely decisions regarding required disclosure.
Our management, with the participation of our CEO and CFO, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of June 30, 2020. Based on that evaluation, our CEO and CFO concluded that, as of that date, our disclosure controls and procedures were effective.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting during the quarter ended June 30, 2020 that have materially affected, or are likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 2,329 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
While we attempt to identify, manage and mitigate risks and uncertainties associated with our business to the extent practical under the circumstances, some level of risk and uncertainty will always be present. Item 1A. Risk Factors of our 2019 Annual Report on Form 10-K describes some of the risks and uncertainties associated with our business. These risks and uncertainties have the potential to materially affect our business, results of operations, financial condition, cash flows, projected results and future prospects. Except for the risk factor discussed below, we do not believe that there have been any material changes to the risk factors disclosed in our 2019 Annual Report on Form 10-K.
The effects of COVID-19 and other potential future public health crises, epidemics, pandemics or similar events on our business, operating results and cash flows are uncertain and could be material.
Our business and financial results may be negatively impacted by health epidemics, pandemics and similar outbreaks. COVID-19, and the global requirements to take action to help limit the spread of the illness, have and will likely continue to impact our ability to carry out our business as usual and may materially adversely impact global economic conditions, our business, results of operations, cash flows and financial condition. Even in those regions where we are currently experiencing business recovery, should those regions fail to fully contain COVID-19 or suffer a recurrence of an outbreak of COVID-19, our businesses located in those regions may not recover as quickly or at all, which could have a material adverse effect on our business and results of operations, including:
- causing significant volatility in demand for our products;
- changes in consumer behavior and preference;
- disruptions in our manufacturing and supply chain operations;
- disruptions to our cost saving programs and restructuring initiatives;
- limitations on our employees’ ability to work and travel;
- significant changes in the economic or political conditions in markets in which we operate; and
- related currency and commodity volatility.
We cannot predict the degree to, or the time period over, which our sales and operations may be affected by this outbreak and preventative measures, and the effects could be material.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-04-01 to 2020-06-30 | $483.9m | us-gaap:Revenues |
| Revenue | 9 months2019-10-01 to 2020-06-30 | $1.46bn | us-gaap:Revenues |
| Cost of revenue | 3 months2020-04-01 to 2020-06-30 | $261.2m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2019-10-01 to 2020-06-30 | $802.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2020-04-01 to 2020-06-30 | $222.7m | us-gaap:GrossProfit |
| Gross profit | 9 months2019-10-01 to 2020-06-30 | $658.8m | us-gaap:GrossProfit |
| Research and development | 3 months2020-04-01 to 2020-06-30 | $12.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2019-10-01 to 2020-06-30 | $40.1m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2020-04-01 to 2020-06-30 | $91.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2019-10-01 to 2020-06-30 | $307.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months2020-04-01 to 2020-06-30 | $15.5m | us-gaap:InterestExpense |
| Interest expense | 9 months2019-10-01 to 2020-06-30 | $43.7m | us-gaap:InterestExpense |
| Income tax | 3 months2020-04-01 to 2020-06-30 | $600.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2019-10-01 to 2020-06-30 | $16.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-04-01 to 2020-06-30 | $4.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months2019-10-01 to 2020-06-30 | $46.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-04-01 to 2020-06-30 | $0.09 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2019-10-01 to 2020-06-30 | $0.86 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-04-01 to 2020-06-30 | $0.09 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2019-10-01 to 2020-06-30 | $0.86 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-04-01 to 2020-06-30 | 54,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2019-10-01 to 2020-06-30 | 54,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2019-10-01 to 2020-06-30 | $118.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2019-10-01 to 2020-06-30 | $26.9m | us-gaap:PaymentsToAcquireProductiveAssets |
| Current assets | At period end2020-06-30 | $1.15bn | us-gaap:AssetsCurrent |
| Total assets | At period end2020-06-30 | $3.47bn | us-gaap:Assets |
| Current liabilities | At period end2020-06-30 | $484.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-06-30 | $2.10bn | us-gaap:Liabilities |
| Long-term debt | At period end2020-06-30 | $1.24bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2020-06-30 | $0 | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2020-06-30 | $1.37bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001096752-20-000044. Last ingested by Listed: Nov 14, 2026, 23:53 ET. Listed shows no prices and gives no investment advice.